Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › Spesolimab

Spesolimab

0 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of Spesolimab

13 trials tracked of Spesolimab: 3 in phase 3 or 4 and 1 with published results.

13Trials tracked
3Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 3 3 Phase 2 8 Phase 1 2
  1. Phase 3 BI655130 (SPESOLIMAB) Induction Treatment in Patients With Moderate-to-severe Ulcerative Colitis Completed
  2. Phase 3 An Expanded Access Trial in Japan to Provide Spesolimab to People With a Flare-up in Generalized Pustular Psoriasis Who Have no Other Treatment Options Completed
  3. Phase 3 An Expanded Access Program in China to Provide Spesolimab to People With a Flare-up in Generalized Pustular Psoriasis Who Have no Other Treatment Options Completed
  4. Phase 2 A Study Testing How BI 655130 Works in Patients With Fistulizing Crohn's Disease Completed
  5. Phase 2 Effisayil™ 1: A Study to Test Spesolimab (BI 655130) in Patients With a Flare-up of a Skin Disease Called Generalized Pustular Psoriasis Completed
  6. Phase 2 BI 655130 Long-term Treatment in Patients With moderate-to Severe Ulcerative Colitis Completed
Show 7 more trials
  1. Phase 2 A Study to Test Whether BI 655130 (Spesolimab) Prevents Flare-ups in Patients With Generalized Pustular Psoriasis Completed
  2. Phase 2 A Study in Patients With Mild or Moderate Ulcerative Colitis Who Take a TNF Inhibitor. The Study Investigates Whether Bowel Inflammation Improves When Patients Take BI 655130 in Addition to Their Current Therapy Completed
  3. Phase 2 Initial Dosing of BI 655130 in Palmoplantar Pustulosis Patients Completed
  4. Phase 2 This Study Tests How BI 655130 Works in Patients With Active Ulcerative Colitis. The Study Also Tests How Well BI 655130 is Tolerated and Whether it Helps the Patients Completed
  5. Phase 2 A Study to Test How Effective and Safe Different Doses of BI 655130 Are in Patients With a Moderate to Severe Form of the Skin Disease Palmoplantar Pustulosis Completed
  6. Phase 1 Spesolimab (BI 655130) Single Dose in Generalized Pustular Psoriasis Completed
  7. Phase 1 Single Rising Dose Trial of Spesolimab (BI 655130) for Healthy Japanese Male Subjects Completed

Showing the 13 most-cited and recently-updated of 13 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
No published articles yet for this medication. Check back soon.